Literature DB >> 30714325

Fecal occult blood test in colorectal cancer screening.

Jing Nan Li1, Si Yi Yuan1.   

Abstract

Colorectal cancer (CRC) is one of the leading causes of cancer-related mortality worldwide. Cancer screening is known to decrease mortality from CRC. One important test for CRC screening is the fecal occult blood test (FOBT), which includes guaiac FOBT and fecal immunological tests. In this review we discussed the development and application of the FOBT in CRC screening.
© 2019 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  colorectal neoplasms; early detection of cancer; fecal immunochemical test; fecal occult blood test; mass screening

Mesh：

Substances：

Year:  2019        PMID： 30714325     DOI： 10.1111/1751-2980.12712

Source DB:  PubMed          Journal:  J Dig Dis        ISSN： 1751-2972            Impact factor:   2.325


  10 in total

1.  The predictive value of routine laboratory tests for colorectal polyps: a retrospective study.

Authors:  Xinyi Feng; Xiuping Jiao; Yemin Xu; Xi Xu; Yan Zhu; Qiang She; Yaoyao Li; Guiqing Li; Jian Wu; Weiming Xiao; Yanbing Ding; Bin Deng
Journal:  J Gastrointest Oncol       Date:  2022-02

2.  Predictors of Colorectal Cancer Screening among Average and High-Risk Saudis Population.

Authors:  Fuad H Abuadas; Abdalkarem F Alsharari; Mohammad H Abuadas
Journal:  J Pers Med       Date:  2022-04-20

3.  Donor Screening Revisions of Fecal Microbiota Transplantation in Patients with Ulcerative Colitis.

Authors:  Xiaochen Zhang; Dai Ishikawa; Kei Nomura; Naoyuki Fukuda; Mayuko Haraikawa; Keiichi Haga; Tomoyoshi Shibuya; Toshihiro Mita; Akihito Nagahara
Journal:  J Clin Med       Date:  2022-02-17       Impact factor: 4.241

Review 4.  Overview of microRNAs as liquid biopsy biomarkers for colorectal cancer sub-type profiling and chemoresistance.

Authors:  Alfred Buhagiar; Elisa Seria; Miriana Borg; Joseph Borg; Duncan Ayers
Journal:  Cancer Drug Resist       Date:  2021-10-26

5.  A Retrospective Study from a Single Center to Identify Hematological Factors that Distinguish Between Patients with Colorectal Carcinoma and Colorectal Adenoma.

Authors:  Jun Huang; Pingping Xu; Youxiang Chen
Journal:  Med Sci Monit       Date:  2022-08-10

6.  Identification of Six Genes as Diagnostic Markers for Colorectal Cancer Detection by Integrating Multiple Expression Profiles.

Authors:  Peijie Wu; Xiuqing Yang; Ling Qiao; Yanju Gong
Journal:  J Oncol       Date:  2022-07-22       Impact factor: 4.501

7.  Impact of Alzheimer's disease and related dementias on colorectal cancer screening utilization, knowledge, and associated health disparities.

Authors:  Gang Lv; Xiaoxia Wang; Xiangxiang Jiang; Minghui Li; Kevin Lu
Journal:  Front Pharmacol       Date:  2022-09-07       Impact factor: 5.988

8.  Health Belief, Behavior Intention, and Health Behaviors Related to Colorectal Cancer Screening in Taiwan.

Authors:  I-Pei Lin; Ding-Tien Chung; Li-Yun Lee; Hsiang-Ju Hsu; Shu-Ching Chen
Journal:  Int J Environ Res Public Health       Date:  2020-06-14       Impact factor: 3.390

9.  Combination of GC-MS based metabolomics analysis with mouse xenograft models reveals a panel of dysregulated circulating metabolites and potential therapeutic targets for colorectal cancer.

Authors:  Juan Ni; Yang Chen; Ningning Li; Diandian Sun; Haixing Ju; Zhongjian Chen
Journal:  Transl Cancer Res       Date:  2021-04       Impact factor: 1.241

Review 10.  Eotaxins and Their Receptor in Colorectal Cancer-A Literature Review.

Authors:  Monika Zajkowska; Barbara Mroczko
Journal:  Cancers (Basel)       Date:  2020-05-28       Impact factor: 6.575
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.